UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________ FORM 8-K ________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2024 ________________________ Xenetic Biosciences, Inc. (Exact name of registrant as specified in charter) Nevada 001-37937 45-2952962 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification N ...